[1] Niu YH, Yin DL, Liu HL, et al. Restoring the Treg cell to Th17 cell ratio may alleviate HBVrelated acuteonchronic liver failure[J]. World J Gastroenterol, 2013, 19(26): 4146-4154.
[2] Sun W, Li WJ, Wu CY, et al. CD45RAFoxp3high but not CD45RA+Foxp3low suppressive T regulatory cells increased in the peripheral circulation of patients with head and neck squamous cell carcinoma and correlated with tumor progression[J]. J Exp Clin Cancer Res, 2014, 33: 35.
[3] Chen B, Zhang D, Zhou J, et al. High CCR6/CCR7 expression and Foxp3+ Treg cell number are positively related to the progression of laryngeal squamous cell carcinoma[J]. Oncol Rep, 2013, 30(3): 1380-1390.
[4] Goswami KK, Barik S, Sarkar M, et al. Targeting STAT3 phosphorylation by neem leaf glycoprotein prevents immune evasion exerted by supraglottic laryngeal tumor induced M2 macrophages[J]. Mol Immunol, 2014, 59(2): 119-127.
[5] Drennan S, Stafford ND, Greenman J, et al. Increased frequency and suppressive activity of CD127(low/-) regulatory T cells in the peripheral circulation of patients with head and neck squamous cell carcinoma are associated with advanced stage and nodal involvement[J]. Immunology, 2013, 140(3): 335-343.
[6] Starska K, Forma E, LewyTrenda I, et al. Expression of CTLA4 and Foxp3 in peripheral blood T cells of patients with squamous cell laryngeal carcinoma[J]. Contemp Oncol (Pozn), 2013, 17(4):370-377.
[7] Hatam LJ, Devoti JA, Rosenthal DW, et al. Immune suppression in premalignant respiratory papillomas: enriched functional CD4+ Foxp3+ regulatory T cells and PD1/PDL1/L2 expression[J]. Clin Cancer Res, 2012, 18(7): 1925-1935.
[8] Cai GM, Huang DH, Dai YZ, et al. Analysis of transcriptional factors and regulation networks in laryngeal squamous cell carcinoma patients with lymph node metastasis[J]. J Proteome Res, 2012, 11(2): 1100-1107.
[9] Papiez P, Bry's M, LewyTrenda I, et al. Expression of Foxp3 and RORgamma t in peripheral blood mononuclear cells in patients with laryngeal carcinoma as indicators of tumor stagepreliminary study[J]. Otolaryngol Pol, 2011, 65 Suppl 5: S109-116.
[10] Liang W, Wang XF. In vitro induction of specific antitumoral immunity against laryngeal carcinoma by using human interleukin-12 genetransfected dendritic cells[J]. Chin Med J (Engl), 2011, 124(9): 1357-1361.
[11]Sirikanjanapong S, Lanson B, Amin M, et al. Collision tumor of primary laryngeal mucosal melanoma and invasive squamous cell carcinoma with IL17A and CD70 gene overexpression[J]. Head Neck Pathol, 2010, 4(4): 295-299. |